Global Artemisinin Combination Therapy Market Size, Status and Forecast 2020-2026

Global Artemisinin Combination Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Artemether+Lumefantrine
1.4.3 Artesunate+Amodiaquine
1.4.4 Dihydroartemisinin+Piperaquine
1.4.5 Artesunate+Mefloquine
1.4.6 Artesunate+Sulfadoxine-Pyrimethamine
1.4.7 Pyronaridine-Artesunate
1.4.8 Other
1.5 Market by Application
1.5.1 Global Artemisinin Combination Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Artemisinin Combination Therapy Market Perspective (2015-2026)
2.2 Artemisinin Combination Therapy Growth Trends by Regions
2.2.1 Artemisinin Combination Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Artemisinin Combination Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Artemisinin Combination Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Artemisinin Combination Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Artemisinin Combination Therapy Players by Market Size
3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2015-2020)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Artemisinin Combination Therapy Market Concentration Ratio
3.2.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2019
3.3 Artemisinin Combination Therapy Key Players Head office and Area Served
3.4 Key Players Artemisinin Combination Therapy Product Solution and Service
3.5 Date of Enter into Artemisinin Combination Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2015-2020)
4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2021-2026)
5 Artemisinin Combination Therapy Breakdown Data by Application (2015-2026)
5.1 Global Artemisinin Combination Therapy Market Size by Application (2015-2020)
5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Artemisinin Combination Therapy Market Size (2015-2020)
6.2 Artemisinin Combination Therapy Key Players in North America (2019-2020)
6.3 North America Artemisinin Combination Therapy Market Size by Type (2015-2020)
6.4 North America Artemisinin Combination Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Artemisinin Combination Therapy Market Size (2015-2020)
7.2 Artemisinin Combination Therapy Key Players in Europe (2019-2020)
7.3 Europe Artemisinin Combination Therapy Market Size by Type (2015-2020)
7.4 Europe Artemisinin Combination Therapy Market Size by Application (2015-2020)
8 China
8.1 China Artemisinin Combination Therapy Market Size (2015-2020)
8.2 Artemisinin Combination Therapy Key Players in China (2019-2020)
8.3 China Artemisinin Combination Therapy Market Size by Type (2015-2020)
8.4 China Artemisinin Combination Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Artemisinin Combination Therapy Market Size (2015-2020)
9.2 Artemisinin Combination Therapy Key Players in Japan (2019-2020)
9.3 Japan Artemisinin Combination Therapy Market Size by Type (2015-2020)
9.4 Japan Artemisinin Combination Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Artemisinin Combination Therapy Market Size (2015-2020)
10.2 Artemisinin Combination Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Artemisinin Combination Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Artemisinin Combination Therapy Market Size by Application (2015-2020)
11 India
11.1 India Artemisinin Combination Therapy Market Size (2015-2020)
11.2 Artemisinin Combination Therapy Key Players in India (2019-2020)
11.3 India Artemisinin Combination Therapy Market Size by Type (2015-2020)
11.4 India Artemisinin Combination Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Artemisinin Combination Therapy Market Size (2015-2020)
12.2 Artemisinin Combination Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Artemisinin Combination Therapy Market Size by Type (2015-2020)
12.4 Central & South America Artemisinin Combination Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 KPC Pharmaceuticals
13.1.1 KPC Pharmaceuticals Company Details
13.1.2 KPC Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction
13.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020))
13.1.5 KPC Pharmaceuticals Recent Development
13.2 Shanghai Fosun Pharmaceutical Industrial Development
13.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details
13.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview and Its Total Revenue
13.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction
13.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Artemisinin Combination Therapy Introduction
13.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Desano Holdings
13.4.1 Desano Holdings Company Details
13.4.2 Desano Holdings Business Overview and Its Total Revenue
13.4.3 Desano Holdings Artemisinin Combination Therapy Introduction
13.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.4.5 Desano Holdings Recent Development
13.5 Calyx Chemicals and Pharmaceuticals
13.5.1 Calyx Chemicals and Pharmaceuticals Company Details
13.5.2 Calyx Chemicals and Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction
13.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.5.5 Calyx Chemicals and Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan Artemisinin Combination Therapy Introduction
13.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview and Its Total Revenue
13.7.3 Novartis Artemisinin Combination Therapy Introduction
13.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Denk Pharma
13.8.1 Denk Pharma Company Details
13.8.2 Denk Pharma Business Overview and Its Total Revenue
13.8.3 Denk Pharma Artemisinin Combination Therapy Introduction
13.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.8.5 Denk Pharma Recent Development
13.9 Hovid Berhad
13.9.1 Hovid Berhad Company Details
13.9.2 Hovid Berhad Business Overview and Its Total Revenue
13.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction
13.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.9.5 Hovid Berhad Recent Development
13.10 Ipca Laboratories
13.10.1 Ipca Laboratories Company Details
13.10.2 Ipca Laboratories Business Overview and Its Total Revenue
13.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction
13.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2015-2020)
13.10.5 Ipca Laboratories Recent Development
13.11 Cipla
10.11.1 Cipla Company Details
10.11.2 Cipla Business Overview and Its Total Revenue
10.11.3 Cipla Artemisinin Combination Therapy Introduction
10.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2015-2020)
10.11.5 Cipla Recent Development
13.12 Aspen Pharmacare Holdings
10.12.1 Aspen Pharmacare Holdings Company Details
10.12.2 Aspen Pharmacare Holdings Business Overview and Its Total Revenue
10.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction
10.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020)
10.12.5 Aspen Pharmacare Holdings Recent Development
13.13 Ajanta Pharma
10.13.1 Ajanta Pharma Company Details
10.13.2 Ajanta Pharma Business Overview and Its Total Revenue
10.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction
10.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020)
10.13.5 Ajanta Pharma Recent Development
13.14 Guilin Pharmaceuticals
10.14.1 Guilin Pharmaceuticals Company Details
10.14.2 Guilin Pharmaceuticals Business Overview and Its Total Revenue
10.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction
10.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020)
10.14.5 Guilin Pharmaceuticals Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Artemisinin Combination Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Artemisinin Combination Therapy Revenue
Table 3. Ranking of Global Top Artemisinin Combination Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Artemether+Lumefantrine
Table 6. Key Players of Artesunate+Amodiaquine
Table 7. Key Players of Dihydroartemisinin+Piperaquine
Table 8. Key Players of Artesunate+Mefloquine
Table 9. Key Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 10. Key Players of Pyronaridine-Artesunate
Table 11. Key Players of Other
Table 12. Global Artemisinin Combination Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Artemisinin Combination Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Artemisinin Combination Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Artemisinin Combination Therapy Market Share by Regions (2015-2020)
Table 16. Global Artemisinin Combination Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Artemisinin Combination Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Artemisinin Combination Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Artemisinin Combination Therapy Players
Table 23. Global Artemisinin Combination Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Artemisinin Combination Therapy Market Share by Players (2015-2020)
Table 25. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2019)
Table 26. Global Artemisinin Combination Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Artemisinin Combination Therapy Product Solution and Service
Table 29. Date of Enter into Artemisinin Combination Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Artemisinin Combination Therapy Market Size Share by Type (2015-2020)
Table 33. Global Artemisinin Combination Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Artemisinin Combination Therapy Market Size Share by Application (2015-2020)
Table 35. Global Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Artemisinin Combination Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 39. North America Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 41. North America Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 45. Europe Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 47. Europe Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 51. China Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 53. China Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 57. Japan Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 59. Japan Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 63. Southeast Asia Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 69. India Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 71. India Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Artemisinin Combination Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Artemisinin Combination Therapy Market Share (2019-2020)
Table 75. Central & South America Artemisinin Combination Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Artemisinin Combination Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Artemisinin Combination Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Artemisinin Combination Therapy Market Share by Application (2015-2020)
Table 79. KPC Pharmaceuticals Company Details
Table 80. KPC Pharmaceuticals Business Overview
Table 81. KPC Pharmaceuticals Product
Table 82. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 83. KPC Pharmaceuticals Recent Development
Table 84. Shanghai Fosun Pharmaceutical Industrial Development Company Details
Table 85. Shanghai Fosun Pharmaceutical Industrial Development Business Overview
Table 86. Shanghai Fosun Pharmaceutical Industrial Development Product
Table 87. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 88. Shanghai Fosun Pharmaceutical Industrial Development Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Desano Holdings Company Details
Table 95. Desano Holdings Business Overview
Table 96. Desano Holdings Product
Table 97. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 98. Desano Holdings Recent Development
Table 99. Calyx Chemicals and Pharmaceuticals Company Details
Table 100. Calyx Chemicals and Pharmaceuticals Business Overview
Table 101. Calyx Chemicals and Pharmaceuticals Product
Table 102. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 103. Calyx Chemicals and Pharmaceuticals Recent Development
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Product
Table 107. Mylan Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 108. Mylan Recent Development
Table 109. Novartis Company Details
Table 110. Novartis Business Overview
Table 111. Novartis Product
Table 112. Novartis Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 113. Novartis Recent Development
Table 114. Denk Pharma Business Overview
Table 115. Denk Pharma Product
Table 116. Denk Pharma Company Details
Table 117. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 118. Denk Pharma Recent Development
Table 119. Hovid Berhad Company Details
Table 120. Hovid Berhad Business Overview
Table 121. Hovid Berhad Product
Table 122. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 123. Hovid Berhad Recent Development
Table 124. Ipca Laboratories Company Details
Table 125. Ipca Laboratories Business Overview
Table 126. Ipca Laboratories Product
Table 127. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 128. Ipca Laboratories Recent Development
Table 129. Cipla Company Details
Table 130. Cipla Business Overview
Table 131. Cipla Product
Table 132. Cipla Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 133. Cipla Recent Development
Table 134. Aspen Pharmacare Holdings Company Details
Table 135. Aspen Pharmacare Holdings Business Overview
Table 136. Aspen Pharmacare Holdings Product
Table 137. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 138. Aspen Pharmacare Holdings Recent Development
Table 139. Ajanta Pharma Company Details
Table 140. Ajanta Pharma Business Overview
Table 141. Ajanta Pharma Product
Table 142. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 143. Ajanta Pharma Recent Development
Table 144. Guilin Pharmaceuticals Company Details
Table 145. Guilin Pharmaceuticals Business Overview
Table 146. Guilin Pharmaceuticals Product
Table 147. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020) (Million US$)
Table 148. Guilin Pharmaceuticals Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artemisinin Combination Therapy Market Share by Type: 2020 VS 2026
Figure 2. Artemether+Lumefantrine Features
Figure 3. Artesunate+Amodiaquine Features
Figure 4. Dihydroartemisinin+Piperaquine Features
Figure 5. Artesunate+Mefloquine Features
Figure 6. Artesunate+Sulfadoxine-Pyrimethamine Features
Figure 7. Pyronaridine-Artesunate Features
Figure 8. Other Features
Figure 9. Global Artemisinin Combination Therapy Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Artemisinin Combination Therapy Report Years Considered
Figure 14. Global Artemisinin Combination Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Artemisinin Combination Therapy Market Share by Regions: 2020 VS 2026
Figure 16. Global Artemisinin Combination Therapy Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Artemisinin Combination Therapy Market Share by Players in 2019
Figure 19. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Combination Therapy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2019
Figure 21. North America Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Artemisinin Combination Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. KPC Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 30. Shanghai Fosun Pharmaceutical Industrial Development Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 32. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 34. Desano Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 36. Calyx Chemicals and Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 40. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 42. Denk Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 44. Hovid Berhad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 46. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 48. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 50. Aspen Pharmacare Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 52. Ajanta Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 54. Guilin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs